Inflammation of the colon.
1The discovery opens the possibility of new treatments for inflammatory bowel disease.
2Similarly, inflammatory bowel disease is a well-known risk factor for colorectal cancer.
3Results: Eighty-one percent of the patients had associated inflammatory bowel disease.
4Whether Wip1 is involved in the regulation of inflammatory bowel disease is unknown.
5Nine of 25 patients with pre-transplant inflammatory bowel disease experienced flare-ups after transplantation.
6Endoscopy remains the cornerstone for diagnosis and evaluation of ileocolonic inflammatory bowel disease.
7Nuclear factor-kappaB-dependent up-regulation of inflammatory cytokines occurs in inflammatory bowel disease.
8He had no history of gastrointestinal surgery and inflammatory bowel disease.
9Dehydroepiandrosterone sulphate concentrations are decreased in patients with inflammatory bowel disease.
10A parallel between interstitial cystitis and inflammatory bowel disease is evident.
11Ulcerative colitis, a related chronic inflammatory bowel disease, can be challenging to treat.
12In humans, ESRP1 is downregulated in inflamed biopsies from inflammatory bowel disease patients.
13Conclusions: Alternative and complementary therapies are frequently used by Italian inflammatory bowel disease patients.
14Future studies identifying targets of inflammatory bowel disease-associated microRNAs may lead to novel therapies.
15Exclusion criteria included history of nephrolithiasis or inflammatory bowel disease.
16ADOA3R is new potential therapeutic target for inflammatory bowel disease.
Translations for inflammatory bowel disease